சர்வதேச மையம் க்கு அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சர்வதேச மையம் க்கு அறிவியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சர்வதேச மையம் க்கு அறிவியல் Today - Breaking & Trending Today

Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic .
Algernon PharmaceuticalsFebruary 1, 2021 GMT
VANCOUVER, British Columbia, Feb. 01, 2021 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has established a clinical research program for the treatment of stroke focused on AP-188 (“N,N-Dimethyltryptamine or DMT”), a known psychedelic compound that is part of the tryptamine family (other drugs in the tryptamine family include psilocybin and psilocin). Algernon plans to be the first company globally to pursue DMT for stroke in humans and is planning to begin a clinical trial as soon as possible in 2021. ....

United States , United Kingdom , British Columbia , South Korea , City Of , Christopherj Moreau , Edmundj Safra , Rick Strassman , Neurosciences At Merck Research Labs , Maastricht University , Neurosciences Institute , Clinical Development Solutions , American Association For The Advancement Of Science , Korea Institute Of Science , Nervous System Drugs Advisory Committee , Company Or Algernon , Department Of Medicine , Health Sciences , Head Of The Centre For Neuropsychopharmacology , Winter Conference For Brain Research , Algernon Pharmaceuticals , Constraint Induced Movement Therapy , Brain Science Institute , Scientific Committee On Drugs , European Brain Council , European College Of Neuropsychopharmacology ,